Economic Evaluation of ASCOT-BPLA: Antihypertensive Treatment With an Amlodipine-Based Regimen Is Cost Effective Compared With an Atenolol-Based Regimen

Heart - United Kingdom
doi 10.1136/hrt.2007.127217

Related search